HIGHLIGHTS
- who: Zhifeng Jia from the Department of Orthopedic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China have published the article: Exploring the relationships between hormone receptor, HER2 status, and bone involvement in the first distant metastases of in Chinese breast cancer patients who lacked HER2 targeted therapy, in the Journal: (JOURNAL)
- what: The authors examined the relationship of the ET compliance status with first BM risk in HR+ patients. Like other retrospective studies, this study has limitations.
- how: Considering those factors the authors designed an epidemiological study of BC patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.